Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is a rare and highly aggressive neoplasm that arises from the pleural, pericardial, or peritoneal lining. Although surgery, chemotherapy, radiotherapy, and combinations of these therapies are used to treat MPM, the median survival of such patients is dismal. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qi, Wang, Wei, Machino, Yusuke, Yamada, Tadaaki, Kita, Kenji, Oshima, Masanobu, Sekido, Yoshitaka, Tsuchiya, Mami, Suzuki, Yui, Nan-ya, Ken-ichiro, Iida, Shigeru, Nakamura, Kazuyasu, Iwakiri, Shotaro, Itoi, Kazumi, Yano, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317781/
https://www.ncbi.nlm.nih.gov/pubmed/25421609
http://dx.doi.org/10.1111/cas.12575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317781/
https://www.ncbi.nlm.nih.gov/pubmed/25421609
http://dx.doi.org/10.1111/cas.12575

Ejemplares similares